NVIDIA Healthcare and Life Sciences Kimberly Powell, VP of Healthcare and Lifesciences January 12, 2026 Except for the historical information contained herein, certain matters in this presentation including, but not limited to, statements as to: expectations with respect to the benefits, impact, performance, and availability of NVIDIA’s products, services and technologies; expectations with respect to NVIDIA’s third-party arrangements, including with its collaborators and partners; expectations with respect to technology developments; expectations with respect to AI and related industries; and other statements that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections based on management’s beliefs and assumptions and on information currently available to management and are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic and political conditions; NVIDIA’s reliance on third parties to manufacture, assemble, package and test NVIDIA’s products; the impact of technological development and competition; development of new products and technologies or enhancements to NVIDIA’s existing product and technologies; market acceptance of NVIDIA’s products or NVIDIA’s partners’ products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of NVIDIA’s products or technologies when integrated into systems; and changes in applicable laws and regulations, as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. Copies of reports filed with the SEC are posted on the company’s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances. Many of the products and features described herein remain in various stages and will be offered on a when-and-if-available basis. The statements within are not intended to be, and should not be interpreted as a commitment, promise, or legal obligation, and the development, release, and timing of any features or functionalities described for our products is subject to change and remains at the sole discretion of NVIDIA. NVIDIA will have no liability for failure to deliver or delay in the delivery of any of the products, features or functions set forth herein. AI Scaling in Healthcare AI Becomes Agentic AI Learns Laws of Nature AI Reaches the Physical World 80% of Startups are Building on Open Models Open Models Reach the Frontier Open Reasoning AI Is the Backbone of Innovation 20 M 40 M 60 M 80 M 100 M 120 M 140 M 160 M 0 M Monthly Hugging Face Downloads Reasoning Models 2024 2025 0 10 20 30 40 50 60 70 80 8/27/2022 3/15/2023 10/1/2023 4/18/2024 11/4/2024 5/23/2025 12/9/2025 DeepSeek V3.2 Release Date Kimi K2 Nemotron Qwen GPT-OSS Frontier Models Open Models Jan 2023 Jan 2024 Jan 2025 Jan 2026 Model Intelligence Nemotron Agentic AI Cosmos Physical AI GR00T Robotics Alpamayo Autonomous Vehicles Clara Biomedical AI Earth-2 AI Physics Language Models Released in 2025 Source: Hugging Face Count excludes quantized models, but includes variants (e.g., reasoning vs. instruct) and fine-tunes of other models 0 25 50 75 100 Google IBM Granite AI2 Microsoft Mistral Z.ai DeepSeek Kimi Minimax Meta Llama OpenAI Alibaba Qwen NVIDIA Generate and Process Data Model Building Train and Customize Evaluate Research Guardrail and Deploy NVIDIA Leads Open Model Ecosystem Agentic AI Has Become “Hirable” 9% 22% 27% 18% 14% 0% 5% 10% 15% 20% 25% 30% Sep 23 Dec 23 Mar 24 Jun 24 Sep 24 Dec 24 Mar 25 Jun 25 Sep 25 U.S. Economy Healthcare (Overall) Health Systems Outpatient Payers Share of U.S. Business With Paid Commercial Licenses for AI Applications $4.9T Healthcare Industry Deploying AI 3x the U.S. Economy Source: Menlo Ventures 2025: The State of AI in Healthcare *Excludes consumer subscriptions like ChatGPT Agents Are Multi Model, Multi Cloud, and Hybrid Cloud App, Data Platforms (MCP) File System Semantic Search Web Search Tool Use Critique Plan Sandbox Reason Memory Frontier Models Router Customized Open Models User or Machine Prompt Response Clinical Conversation Agents Health Agent Developer Platform Healthcare Workforce Agents Healthcare Agents Clinical Trial Agents Disease Modeling Agents Commercial Field Agents Clinical Agents Agentic Digital Health Ecosystem on NVIDIA Clinical Operations Clinical Development Patient Experience Virtual Care Clinician Experience Patient Monitoring Analytics Operations Agents Accelerate Science AI Scientist Agent User Computational Dry Lab Robotic Wet Lab Prompt Response AI Co-Scientist Scientific Superintelligence Agents for Multi-Omics Drug Discovery Science Agents Agents Enter The Lab Announcing Thermo Fisher Scientific Builds AI Infrastructure to Advance Scientific Instrumentation and Accelerate Lab Performance Experiment Agent Protocol Agent QC Agent Analytics Agent Scaling Robot Intelligence for the Real World Specialist Generalist-Specialist Deep proficiency Broad scope, deep proficiency Generalist Broad scope Deploy Physical AI 3-Computer Platform Simulate Cosmos Train Isaac Gr00T Industry Leaders Building on NVIDIA Isaac and GR00T Cosmos Physical AI Isaac GR00T Robotics “NeurIPS 2025: Biology’s Transformer Moment” Genetic Engineering & Biotechnology News, December 2025 “An AI Revolution in Drugmaking Is Under Way” Economist, January 2026 “AI-Enabled Drug Discovery Reaches Clinical Milestone” Nature Medicine, July 2025 Announcing New NVIDIA Clara Open Models Proteina RNAProNEW CodonFM KERMT ReaSyn v2NEW Announcing The NVIDIA BioNeMo Platform New open-source models, libraries, and training recipes Data 455K Synthetic Proteins Libraries and Tools Training and Customization BioNeMo Framework BioNeMo RecipesNEW Blueprints Virtual Screening Protein Design Models cuEquivariance nvMolKitNEW Parabricks CUDA-X Data Science Proteina CodonFM KERMT ReaSyn v2NEW RNAProNEW Expanding the BioNeMo Ecosystem to Enterprise Platforms Scientific Data Discovery PlatformEnd-to-End Drug AI PlatformGene Therapy Design Platform AI Scientist Agent Computational Dry Lab Robotic Wet Lab User Prompt Response Growing NVIDIA BioNeMo Ecosystem AI Drug Discovery Data and Agents Laboratories and Robots AI Scaling in Healthcare